Development of abbapolin inhibitors of the PLK1 PBD as potential therapeutics for prostate and other challenging cancers-MedSci.cn

Development of abbapolin inhibitors of the PLK1 PBD as potential therapeutics for prostate and other challenging cancers

Stafford, J; Chapagai, D; Merhej, G; Pressley, J; Nageswara-Rao, C; Wyatt, M; Mcinnes, C

CANCER RESEARCH, 2023; 83 (7):

科室
- - 订阅+
  - 更多科室
工具
服务